Multinational pharmaceutical company GSK’s commitment to invest up to $800 million in its facility near Marietta may have ...

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any ...

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia ... Defendants represented to investors that GSK removed Zantac from the market ...

BENSALEM, Pa., March 13, 2025 (GLOBE NEWSWIRE ... and/or misleading statements and/or failed to disclose that: (1) GSK was fully aware of the source of NDMA and had been for nearly 40 years ...

BENSALEM, Pa., Feb. 18, 2025 /PRNewswire/ -- The Law ... to lead the securities fraud class action lawsuit against GSK plc. ("GSK" or the "Company") (NYSE: GSK). IF YOU ARE AN INVESTOR WHO ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Pa­trizia Cavaz­zoni, the FDA’s for­mer head of drug reg ... Lynch has been elected to its board of directors, effective February 19. GSK announced Dr. Gavin Screaton will join the board of directors ...

He is the brother of Yu Xue, who worked as a scientist at GSK in Pennsylvania and is one of four other people who have previously pleaded guilty to charges in connection with the case.

The deal follows GSK’s decision to pump $800m into a new vaccines drug substance facility and R&D pilot plant in the US, with the planned investment set to double the size of the company’s site in ...

Universal Health Services, Inc. announced today that Steve Filton, Executive Vice President and Chief Financial Officer will participate in a fireside chat at KeyBanc Capital Markets Virtual ...